Pfizer - Defining precision in mCSPC (mAPMN/S): The clinical impact of PARPi+ARPi combinations

Name: Pfizer - Defining precision in mCSPC (mAPMN/S): The clinical impact of PARPi+ARPi combinations
Start: 2026-12-04T16:00
End: 2026-12-04T17:00
Location: Suntec Convention Centre

ESMO Asia 2026 · 4 December 2026 · 16:00–17:00 · Hall 407

Pfizer - Defining precision in mCSPC (mAPMN/S): The clinical impact of PARPi+ARPi combinations was a session at ESMO Asia 2026 on 4 December 2026 in Singapore, with 3 speakers on record.

Speakers

Elena Castro Marcos — Chair Hospital Universitario 12 de Octubre
Nobuaki Matsubara — Speaker National Cancer Center Hospital East
Yao Zhu — Speaker Fudan University Shanghai Cancer Center